Sarika N. Rao, D.O.

Publications

  1. Rao SN, Smallridge RC. Anaplastic thyroid cancer: An update. Best Pract Res Clin Endocrinol Metab. 2022 May 27; 101678 [Epub ahead of print]
    View PubMed
  2. Hassan Nelson L, Fuentes-Bayne H, Yin J, Asmus E, Ryder M, Morris JC, Hilger CR, Bible KC, Chintakuntlawar AV, Rao SN. Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas. J Endocr Soc. 2022 May 1; 6 (5):bvac044 Epub 2022 Mar 22
    View PubMed
  3. Srougi V, Bancos I, Daher M, Lee JE, Graham PH, Karam JA, Henriquez A, Mckenzie TJ, Sada A, Bourdeau I, Poirier J, Vaidya A, Abbondanza T, Kiernan CM, Rao SN, Hamidi O, Sachithanandan N, Hoff AO, Chambo JL, Almeida MQ, Habra MA, Fragoso MCBV. Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival. J Clin Endocrinol Metab. 2022 Mar 24; 107 (4):964-971
    View PubMed
  4. Gomes-Lima CJ, Shobab L, Wu D, Ylli D, Bikas A, McCoy M, Feldman R, Lee W, Rao SN, Jensen K, Vasko V, Castro LC, Jonklaas J, Wartofsky L, Burman KD. Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ? Front Endocrinol (Lausanne). 2021; 12:623182. Epub 2021 Feb 25.
    View PubMed
  5. Rao SN, Bernet V. Indeterminate thyroid nodules in the era of molecular genomics. Mol Genet Genomic Med. 2020 Sep; 8 (9):e1288 Epub 2020 May 21
    View PubMed
  6. Gomes-Lima CJ, Wu D, Rao SN, Punukollu S, Hritani R, Zeymo A, Deeb H, Mete M, Aulisi EF, Van Nostrand D, Jonklaas J, Wartofsky L, Burman KD. Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes. J Endocr Soc. 2019 Feb 1; 3 (2):359-371 Epub 2018 Nov 21
    View PubMed
  7. Rao SN, Cabanillas ME. Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond. J Endocr Soc. 2018 Oct 1; 2 (10):1109-1130 Epub 2018 Aug 13
    View PubMed
  8. Rao SN, Zafereo M, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, Gunn GB, Lu C, Ferrarotto R, Lai SY, Cabanillas ME. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid. 2017 May; 27 (5):672-681 Epub 2017 Feb 16
    View PubMed
  9. Siddiqui UM, Rao SN, Galera PK, Islam N, Torres MS. Mantle Cell Lymphoma in the Thyroid: A Rare Presentation. Case Rep Pathol. 2017; 2017:6749801 Epub 2017 Dec 25
    View PubMed
  10. Xu JY, Murphy WA Jr, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 Dec; 101 (12):4871-4877 Epub 2016 Sept 23
    View PubMed
  11. Cabanillas ME, Busaidy NL, Khan S, Gunn GB, Dadu R, Rao SN, Waguespack S. Molecular Diagnostics and Anaplastic Thyroid Carcinoma: the time has come to harvest the high hanging fruit Int J of End Onc. 2016; 3:221-233.
  12. Toledo RA, Qin Y, Cheng ZM, Gao Q, Iwata S, Silva GM, Prasad ML, Ocal IT, Rao S, Aronin N, Barontini M, Bruder J, Reddick RL, Chen Y, Aguiar RC, Dahia PL. Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas. Clin Cancer Res. 2016 May 1; 22 (9):2301-10 Epub 2015 Dec 23
    View PubMed
  13. Rao SN, Habra MA. 5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications. Horm Cancer. 2016 Feb; 7 (1):17-23 Epub 2015 Dec 10
    View PubMed
  14. Kotwal A, Rao SN, Haas R. Ipilimumab Induced Hypophysitis May Not Affect All Pituitary Cell Lines: A Case Study J Endocrinol Metab. 2015; 5:299-303.
  15. Rao SN, Swami A, Khan A, Toke M, Whalen G, Fischer A, Torres MS. Metastatic mesothelioma to the thyroid. Cytojournal. 2014; 11:11 Epub 2014 May 22
    View PubMed
PST-20453981